Targovax Oy
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma Patients (NCT05561491) | Targovax Oy | 2024-01-01 |
Track Targovax Oy automatically
Every clearance here is in the API, with alerts when new ones post.